This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.
The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.
The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.
The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.
Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.
In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.
Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance.
North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.
The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.
The medical device reimbursement market research report is one of a series of new reports that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.
The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.
The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.
The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.
Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.
In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.
Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance.
North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.
The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.
The medical device reimbursement market research report is one of a series of new reports that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Medical Devices Reimbursement Market Characteristics3. Medical Devices Reimbursement Market Trends and Strategies4. Medical Devices Reimbursement Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Medical Devices Reimbursement Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Medical Devices Reimbursement Market34. Recent Developments in the Medical Devices Reimbursement Market
5. Global Medical Devices Reimbursement Growth Analysis and Strategic Analysis Framework
6. Medical Devices Reimbursement Market Segmentation
7. Medical Devices Reimbursement Market Regional and Country Analysis
8. Asia-Pacific Medical Devices Reimbursement Market
9. China Medical Devices Reimbursement Market
10. India Medical Devices Reimbursement Market
11. Japan Medical Devices Reimbursement Market
12. Australia Medical Devices Reimbursement Market
13. Indonesia Medical Devices Reimbursement Market
14. South Korea Medical Devices Reimbursement Market
15. Western Europe Medical Devices Reimbursement Market
16. UK Medical Devices Reimbursement Market
17. Germany Medical Devices Reimbursement Market
18. France Medical Devices Reimbursement Market
19. Italy Medical Devices Reimbursement Market
20. Spain Medical Devices Reimbursement Market
21. Eastern Europe Medical Devices Reimbursement Market
22. Russia Medical Devices Reimbursement Market
23. North America Medical Devices Reimbursement Market
24. USA Medical Devices Reimbursement Market
25. Canada Medical Devices Reimbursement Market
26. South America Medical Devices Reimbursement Market
27. Brazil Medical Devices Reimbursement Market
28. Middle East Medical Devices Reimbursement Market
29. Africa Medical Devices Reimbursement Market
30. Medical Devices Reimbursement Market Competitive Landscape and Company Profiles
31. Medical Devices Reimbursement Market Other Major and Innovative Companies
35. Medical Devices Reimbursement Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Medical Devices Reimbursement Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical devices reimbursement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical devices reimbursement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Payer: Public; Private2) By Claims: Underpaid; Full
3) By Healthcare Setting: Hospitals; Outpatient Facilities; Other Healthcare Settings
Subsegments:
1) By Public: Government Health Insurance Programs; National Health Services; Social Health Insurance2) By Private: Private Health Insurance Plans; Employer-Sponsored Health Insurance; Out-of-Pocket Reimbursement
Key Companies Mentioned: UnitedHealth Group; CVS Health Corporation; Cigna Corporation; Anthem Insurance Companies Inc.; Axa S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Medical Devices Reimbursement market report include:- UnitedHealth Group
- CVS Health Corporation
- Cigna Corporation
- Anthem Insurance Companies Inc.
- Axa S.A.
- Assicurazioni Generali SpA
- Humana Inc.
- Reliance Nippon Life Insurance Company Limited
- MetLife Services and Solutions LLC
- Aetna Inc.
- New York Life Insurance
- Nationwide Mutual Insurance Company
- American International Group Inc.
- Allstate Insurance Company
- BNP Paribas S.A.
- Zurich Insurance Group Ltd.
- Aegon Life Insurance Company
- Aviva plc
- WellCare Health Plans Inc.
- Pacific Life Insurance Company
- Allianz SE
- Bright House Financial Inc.
- Globe Life Inc.
- Munich Re Group
- Symetra Life Insurance Company
- Sumitomo Life Insurance Company
- NAMSA Inc.
- Colonial Penn Life Insurance Company
- Musculoskeletal Clinical Regulatory Advisers LLC
- Assurity Life Insurance
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 653.64 Billion |
| Forecasted Market Value ( USD | $ 924.83 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
